Dyne Therapeutics

Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes
Biotech

Dyne readies FDA push after DMD exon 51 med excels in trial

The drug “has the potential to transform the care of those living with DMD amenable to exon 51 skipping,” Dyne CEO John Cox said in a statement.
Eric Sagonowsky Dec 8, 2025 10:50am
parasailing over clouds in Salzburg Austria

Sarepta shakes up C-suite amid org overhaul—Chutes & Ladders

Jul 18, 2025 8:30am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

AIRNA appoints Elevidys architect as CMO—Chutes & Ladders

Apr 18, 2025 8:30am
parachute chutes

Former FDA deputy joins AI biotech's board—Chutes & Ladders

Mar 21, 2025 8:30am
Charming view of the seaside resort town of Kas in Turkey Romantic lighthouse at the entrance to the port and a paraglider f

BMS vet answers Foghorn’s call for CBO—Chutes & Ladders

Sep 6, 2024 8:30am
Board room C-suite meeting contract

Dyne shakes up C-suite after hazy DMD data drop

Sep 3, 2024 11:49am